We have found a significantly lower percentage (%) of monocytes (CD11bhighCD4mid) and DCs (CD1chighCD11blow) expressing TYRO3 in patients with MS compared to HIMS or HC groups (Fig 1B, 1C, 1E and 1F, respectively). This evidence concerns the gene TYRO3 and myeloid sarcoma.